(Q43585614)

English

In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

0 references

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Kays MB

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Denys GA

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

413-424

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumococcal macrolide resistance--myth or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumococcal macrolide resistance-not a myth

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of intracellular and extracellular concentrations of macrolides

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrapulmonary concentrations of antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clarithromycin pharmacokinetics in healthy young and elderly volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of grapefruit juice on clarithromycin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic interaction between ritonavir and clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Breakthrough sepsis in macrolide-resistant pneumococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of azithromycin in patients with impaired hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of azithromycin in normal and impaired renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980046-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(01)80046-1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43585614&oldid=2144119382"